Skip to main content

Table 4 Treatment of patients at reporting tertiary paediatric centre

From: Childhood interstitial lung diseases in immunocompetent children in Australia and New Zealand: a decade’s experience

 

N (%)

All cases

Diagnosis < 2 years

Diagnosis ≥ 2 years

  

No. reported

(Max 107)

N (%)

No.reported (Max 66)a

N (%)

No. reported (Max 40)a

Treatment given

Steroids

62 (59.6)

104

33 (52.4)

63

29 (72.5)

40

  Response seen

28 (62.2)

45

16 (72.7)

22

12 (52.2)

23

Hydrochloroquine

36 (34.6)

104

24 (38.1)

63

12 (30.0)

40

  Response seen

12 (63.1)

19

9 (69.2)

13

3 (50.0)

6

Azithromycin

26 (25.0)

104

17 (27.0)

63

9 (22.5)

40

  Response seen

6 (50.0)

12

2 (40.0)

5

4 (57.1)

7

Azathioprine

4 (3.9)

103

1 (1.6)

62

3 (7.5)

40

  Response seen

1 (50.0)

2

1 (100.0)

1

0 (0.0)

0

Cyclophosphamide

6 (5.8)

104

0 (0.0)

63

6 (15.0)

40

  Response seen

1 (33.3)

3

-

0

1 (33.3)

3

Oxygen

23 (56.1)

41

17 (56.7)

30

6 (54.5)

11

  Response seen

4 (80.0)

5

4 (100.0)

4

0 (0.0)

1

  1. a Age at diagnosis was not documented for 1 subject